((1R,5S,6R)-3-Benzyl-3-azabicyclo[3.1.0]hexan-6-yl)methanol
≥95%
- Product Code: 112982
CAS:
134575-07-8
| Molecular Weight: | 203.28 g./mol | Molecular Formula: | C₁₃H₁₇NO |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD16140332 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, dry and sealed |
Product Description:
This compound is primarily utilized in the development of pharmaceutical agents, particularly in the synthesis of central nervous system (CNS) drugs. Its unique bicyclic structure makes it a valuable intermediate for creating molecules that interact with neurotransmitter systems, potentially leading to treatments for neurological disorders such as depression, anxiety, and schizophrenia. Additionally, it serves as a key building block in the design of compounds targeting specific receptors or enzymes in the brain, enhancing their efficacy and selectivity. Researchers also explore its use in medicinal chemistry for optimizing drug-like properties, such as bioavailability and metabolic stability, to improve therapeutic outcomes.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | ฿1,116.00 |
+
-
|
| 1.000 | 10-20 days | ฿1,539.00 |
+
-
|
| 5.000 | 10-20 days | ฿5,787.00 |
+
-
|
| 25.000 | 10-20 days | ฿20,133.00 |
+
-
|
((1R,5S,6R)-3-Benzyl-3-azabicyclo[3.1.0]hexan-6-yl)methanol
This compound is primarily utilized in the development of pharmaceutical agents, particularly in the synthesis of central nervous system (CNS) drugs. Its unique bicyclic structure makes it a valuable intermediate for creating molecules that interact with neurotransmitter systems, potentially leading to treatments for neurological disorders such as depression, anxiety, and schizophrenia. Additionally, it serves as a key building block in the design of compounds targeting specific receptors or enzymes in the brain, enhancing their efficacy and selectivity. Researchers also explore its use in medicinal chemistry for optimizing drug-like properties, such as bioavailability and metabolic stability, to improve therapeutic outcomes.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :